文献速递乳腺外科

三阴性乳腺癌保乳手术与乳房切除术结局的荟萃分析

Outcomes after breast-conserving surgery or mastectomy in patients with triple-negative breast cancer: meta-analysis.
PubMed 文献 · Br J Surg · 2021-01-01

保乳组局部复发(OR 0.64)和远处转移(OR 0.70)风险更低,全因死亡风险也显著更低(HR 0.78),但需谨慎解读因选择偏倚。临床可行时可考虑保乳。

要点

  • 三阴性乳腺癌保乳手术不增加局部复发风险,OR 0.64(95%CI 0.48-0.85)
  • 保乳组远处转移风险更低(OR 0.70),但随年龄和随访延长差异减弱
  • 保乳组全因死亡风险显著更低(HR 0.78,95%CI 0.69-0.89)

核心结论

  • 三阴性乳腺癌患者选择保乳手术者预后不劣于乳房切除术,临床可行时可提供保乳。
  • 结果需谨慎解读,因纳入研究可能存在保乳与乳房切除的选择差异。

研究设计与样本

  • 9828例(49.6%)行保乳手术,9991例(50.4%)行乳房切除术。
  • 采用随机效应模型合并估计值,并用单变量荟萃回归评估研究水平协变量效应。

主要发现

  • 肿瘤较小者更可能选择保乳(T1肿瘤合并OR 1.95,95%CI 1.64-2.32,P<0.001)。
  • 保乳组局部复发合并OR 0.64(95%CI 0.48-0.85,P=0.002),显著低于乳房切除组。
  • 保乳组远处转移合并OR 0.70(95%CI 0.53-0.94,P=0.02),但差异随研究水平年龄和随访时间增加而减弱。
  • 保乳组全因死亡合并HR 0.78(95%CI 0.69-0.89,P<0.001),显著低于乳房切除组。

临床怎么用

  • 三阴性乳腺癌临床可行时可考虑保乳手术,不因分子分型而排除保乳。
  • 决策时应综合肿瘤大小等因素,并告知选择偏倚可能影响证据强度。

局限性

  • 纳入研究可能存在保乳与乳房切除的选择差异,导致结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In patients with triple-negative breast cancer (TNBC), oncological and survival outcomes based on locoregional treatment are poorly understood. In particular, the safety of breast-conserving surgery (BCS) for TNBC has been questioned. METHODS: A meta-analysis was performed to evaluate locoregional recurrence (LRR), distant metastasis (DM), and overall survival (OS) rates in patients with TNBC who had breast-conserving surgery versus mastectomy. Estimates were pooled in random-effects analysis. The effect of study-level co-variables was assessed by univariable metaregression. RESULTS: Fourteen studies, including 19 819 patients operated for TNBC met the inclusion criteria; 9828 patients (49.6 per cent) underwent BCS and 9991 (50.4 per cent) had a mastectomy. Patients with smaller tumours were more likely to be selected for BCS (pooled odds ratio (OR) for T1 tumours 1.95, 95 per cent c.i. 1.64 to 2.32; P < 0.001). The pooled OR for LRR was 0.64 (0.48 to 0.85; P = 0.002), indicating a statistically significantly lower odds of LRR among women who had BCS relative to mastectomy. The pooled OR for DM was 0.70 (0.53 to 0.94; P = 0.02), indicating a lower odds of DM among women who had BCS; however, this difference diminished with increasing study-level age and follow-up time. A pooled hazard ratio of 0.78 (0.69 to 0.89; P < 0.001) showed a significantly lower hazard for all-cause mortality among women undergoing BCS versus mastectomy. CONCLUSION: These results should be interpreted cautiously owing to likely differences in selection for BCS or mastectomy in the included studies. Patients with TNBC selected for BCS do not, however, have a worse prognosis than those treated with mastectomy, and breast conservation can be offered when feasible clinically.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Fancellu A, Houssami N, Sanna V, et al. Outcomes after breast-conserving surgery or mastectomy in patients with triple-negative breast cancer: meta-analysis. Br J Surg. 2021. PMID: 34057990. doi:10.1093/bjs/znab145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。